18F-FDG PET/CT for Diagnosis of Diabetic Foot Osteomyelitis
for Diabetic Foot Infections
1 location in Dallas
Sponsor: Jewish General Hospital
Sex: All·Age: 18+
Code: NCT07828691·Not Yet Recruiting·Listed Sep 18, 2026
Clinical Trials at UT Southwestern Medical Center
As of September 2026, 167 paid clinical trials are recruiting at UT Southwestern Medical Center, located at UT Southwestern Medical Center: Research Department, 6000 Harry Hines Blvd, Dallas, TX 75235, phone (214) 633-0022 in Dallas, Texas. Active studies at this site cover conditions such as Heart Failure, Breast Cancer and Obesity. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
Filter results
Newly added in Dallas
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
Pregnenolone Treatment for Alcohol Use Disorder and Major Depressive Disorder
for Alcohol Use Disorder (AUD)
Sites in Dallas & Richardson
Sponsor: Sherwood Brown, MD, PhD
Sex: All·Age: 21 - 55
Code: NCT07734701·Phase 2·Not Yet Recruiting·Listed Jul 29, 2026
169 clinical trials at UT Southwestern Medical Center
·Clear filters· Get a weekly email when new trials open in Dallas, TX.
A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
for Overweight
Drug: Eloralintide
Sites in Dallas, Wylie +57 more locations
Sponsor: Eli Lilly and Company
Sex: All·Age: 18+
Code: NCT07392190·Phase 3·Recruiting·Listed Feb 2026
A Phase 3 Trial to Compare IV BCV Versus IV CDV for Treatment of Adenovirus Infection After Allo-HCT
for Adenovirus Infections
Sites in Dallas +31 more locations
Sponsor: SymBio Pharmaceuticals
Sex: All·Age: 2 Months+
Code: NCT07387367·Phase 3·Recruiting·Listed Feb 2026
A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes
for Obesity
Drug: Eloralintide
Sites in Dallas, Bellaire +39 more locations
Sponsor: Eli Lilly and Company
Sex: All·Age: 18+
Code: NCT07321886·Phase 3·Recruiting·Listed Jan 2026
Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer
for Carcinoma, Renal Cell
Drug: PF-08634404
Sites in Dallas, Irving +138 more locations
Sponsor: Pfizer
Sex: All·Age: 18+
Code: NCT07227415·Phase 1, Phase 2·Recruiting·Listed Nov 2025
A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer
for Squamous Cell Carcinoma of Head and Neck
Drug: Amivantamab
Sites in Dallas, Waco +45 more locations
Sponsor: Janssen Research & Development, LLC
Sex: All·Age: 18+
Code: NCT07276399·Phase 3·Recruiting·Listed Dec 2025
A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer
for Prostatic Neoplasms, Castration-Resistant
Drug: Pasritamig
Sites in Dallas, Austin +51 more locations
Sponsor: Janssen Research & Development, LLC
Sex: All·Age: 18+
Code: NCT07225946·Phase 3·Recruiting·Listed Nov 2025
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
for Breast Neoplasms
Sites in Dallas, Abilene +124 more locations
Sponsor: Eli Lilly and Company
Sex: All·Age: 18+
Code: NCT07174336·Phase 3·Recruiting·Listed Sep 2025
Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)
for Elevated Lp(a)
Drug: Muvalaplin
Sites in Dallas, Mesquite +155 more locations
Sponsor: Eli Lilly and Company
Sex: All·Age: 18+
Code: NCT07157774·Phase 3·Recruiting·Listed Sep 2025
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
for Carcinoma, Transitional Cell
Sites in Dallas, Tyler +62 more locations
Sponsor: Eli Lilly and Company
Sex: All·Age: 18+
Code: NCT07218380·Phase 3·Recruiting·Listed Oct 2025
A Study of Brenipatide in Participants With Moderate-to-Severe Alcohol Use Disorder
for Alcohol Use Disorder
Drug: Brenipatide
Sites in Dallas, Richardson +28 more locations
Sponsor: Eli Lilly and Company
Sex: All·Age: 18 - 75
Code: NCT07219966·Phase 3·Recruiting·Listed Oct 2025
A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma
for Multiple Myeloma
Sites in Dallas, Austin +37 more locations
Sponsor: Janssen Research & Development, LLC
Sex: All·Age: 18+
Code: NCT07258511·Phase 3·Recruiting·Listed Dec 2025
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
for Ovarian Neoplasms
Sites in Dallas, Austin +85 more locations
Sponsor: Eli Lilly and Company
Sex: All·Age: 18+
Code: NCT07213804·Phase 3·Recruiting·Listed Oct 2025
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
for Carcinoma, Non-Small-Cell Lung
Drug: Amivantamab
Sites in Dallas, Fort Worth +123 more locations
Sponsor: Janssen Research & Development, LLC
Sex: All·Age: 18+
Code: NCT06667076·Phase 2·Recruiting·Listed Oct 2024
A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
for Crohn Disease
Sites in Dallas, Carrollton +51 more locations
Sponsor: Janssen Research & Development, LLC
Sex: All·Age: 18+
Code: NCT07196722·Phase 2, Phase 3·Recruiting·Listed Sep 2025
A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy
for Colorectal Neoplasms
Drug: Amivantamab
Sites in Dallas, Tyler +66 more locations
Sponsor: Janssen Research & Development, LLC
Sex: All·Age: 18+
Code: NCT06750094·Phase 3·Recruiting·Listed Dec 2024
A Study of Pasritamig With or Without JNJ-87189401 Versus Placebo for Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC)
for Metastatic Castration-resistant Prostatic Neoplasms
Drug: Pasritamig
Sites in Dallas, Wichita Falls +50 more locations
Sponsor: Janssen Research & Development, LLC
Sex: Male·Age: 18+
Code: NCT07164443·Phase 3·Recruiting·Listed Sep 2025
A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)
for Lymphoma, Large B-Cell, Diffuse
Drug: Polatuzumab Vedotin
Sites in Dallas, Palestine +69 more locations
Sponsor: Merck Sharp & Dohme LLC
Sex: All·Age: 18+
Code: NCT06890884·Phase 2·Recruiting·Listed Mar 2025
Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)
for Plaque Psoriasis
Drug: Deucravacitinib
Sites in Dallas, Arlington +95 more locations
Sponsor: Bristol-Myers Squibb
Sex: All·Age: 40+
Code: NCT07116967·Phase 3·Recruiting·Listed Aug 2025
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
for Neoplasms
Sites in Dallas, Houston +75 more locations
Sponsor: Celgene
Sex: All·Age: All ages
Code: NCT03435796·Phase 2, Phase 3·Recruiting·Listed Feb 2018
A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)
for Colon Adenocarcinoma
Drug: Calderasib
Sites in Dallas, Denison +39 more locations
Sponsor: Merck Sharp & Dohme LLC
Sex: All·Age: 18+
Code: NCT06997497·Phase 3·Recruiting·Listed May 2025
Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC
for High-Risk Non-Muscle-Invasive Bladder Cancer
Sites in Dallas, Arlington +73 more locations
Sponsor: CG Oncology, Inc.
Sex: All·Age: 18+
Code: NCT06567743·Phase 2·Recruiting·Listed Aug 2024
A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)
for Breast Neoplasms
Sites in Dallas, Fort Worth +39 more locations
Sponsor: Merck Sharp & Dohme LLC
Sex: All·Age: 18+
Code: NCT06312176·Phase 3·Recruiting·Listed Mar 2024
A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)
for Carcinoma, Non-Small-Cell Lung
Drug: Intismeran autogene
Sites in Dallas, Tyler +48 more locations
Sponsor: Merck Sharp & Dohme LLC
Sex: All·Age: 18+
Code: NCT06623422·Phase 3·Recruiting·Listed Oct 2024
A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)
for Geographic Atrophy
Sites in Dallas, Willow Park +43 more locations
Sponsor: Janssen Research & Development, LLC
Sex: All·Age: 60+
Code: NCT06635148·Phase 2, Phase 3·Recruiting·Listed Oct 2024
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
for Prostate Cancer
Sites in Dallas, Houston +48 more locations
Sponsor: Merck Sharp & Dohme LLC
Sex: Male·Age: 18+
Code: NCT06925737·Phase 3·Recruiting·Listed Apr 2025
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
for Bladder Carcinoma
Sites in Dallas, San Antonio +23 more locations
Sponsor: Guardant Health, Inc.
Sex: All·Age: 18+
Code: NCT05059444·Recruiting·Listed Sep 2021
Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure
for Cardiovascular Diseases
Sites in Dallas, Plano +45 more locations
Sponsor: BrioHealth Solutions, Inc.
Sex: All·Age: 18 - 100
Code: NCT06310031·Recruiting·Listed Mar 2024
A Study of Lebrikizumab (LY3650150) in Participants With Chronic Rhinosinusitis and Nasal Polyps Treated With Intranasal Corticosteroids (CONTRAST-NP)
for Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)
Sites in Dallas, McKinney +39 more locations
Sponsor: Eli Lilly and Company
Sex: All·Age: 12+
Code: NCT06338995·Phase 3·Recruiting·Listed Apr 2024
LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve
for Superficial Bladder Cancer
Sites in Dallas, Austin +46 more locations
Sponsor: enGene, Inc.
Sex: All·Age: 18+
Code: NCT04752722·Phase 1, Phase 2·Recruiting·Listed Feb 2021
DALY II USA/ MB-CART2019.1 for DLBCL
for Refractory Diffuse Large B Cell Lymphoma (DLBCL)
Sites in Dallas, Houston +26 more locations
Sponsor: Miltenyi Biomedicine GmbH
Sex: All·Age: 18+
Code: NCT04792489·Phase 2·Recruiting·Listed Mar 2021
LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC
for Metastatic Non-small Cell Lung Cancer
Sites in Dallas, Richardson +35 more locations
Sponsor: NovoCure GmbH
Sex: All·Age: 18+
Code: NCT06216301·Phase 3·Recruiting·Listed Jan 2024
Study of NRTX-1001 Neural Cell Therapy in Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy (EPIC (EPIlepsy Cell Therapy))
for Mesial Temporal Lobe Epilepsy
Sites in Dallas, Houston +33 more locations
Sponsor: Neurona Therapeutics
Sex: All·Age: 18 - 75
Code: NCT05135091·Phase 3·Recruiting·Listed Nov 2021
The PREDICT Registry:
for DCIS
Sites in Dallas, Plano +28 more locations
Sponsor: PreludeDx
Sex: Female·Age: 30 - 85
Code: NCT03448926·Recruiting·Listed Feb 2018
A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
for Locally Advanced Solid Tumors
Drug: Repotrectinib
Sites in Dallas, Houston +9 more locations
Sponsor: Turning Point Therapeutics, Inc.
Sex: All·Age: 12+
Code: NCT03093116·Phase 1, Phase 2·Recruiting·Listed Mar 2017
A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma
for Metastatic Uveal Melanoma
Drug: Nivolumab
Sites in Dallas, Houston +27 more locations
Sponsor: Replimune, Inc.
Sex: All·Age: All ages
Code: NCT06581406·Phase 2, Phase 3·Recruiting·Listed Sep 2024
Endovascular AAA Intervention Using the GORE® EXCLUDER® Conformable AAA Endoprosthesis or Iliac Branch Endoprosthesis
for AAA - Abdominal Aortic Aneurysm
Sites in Dallas, Plano +54 more locations
Sponsor: W.L.Gore & Associates
Sex: All·Age: 18+
Code: NCT06218875·Recruiting·Listed Jan 2024
Study of Arlocabtagene Autoleucel (BMS-986393) a GPRC5D-directed CAR T Cell Therapy in Adult Participants With Relapsed or Refractory Multiple Myeloma
for Multiple Myeloma
Sites in Dallas, Houston +36 more locations
Sponsor: Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
Sex: All·Age: 18+
Code: NCT06297226·Phase 2·Recruiting·Listed Mar 2024
A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)
for Chronic Graft-Versus-Host Disease (cGVHD)
Sites in Dallas, Austin +24 more locations
Sponsor: Deciphera Pharmaceuticals, LLC
Sex: All·Age: 18+
Code: NCT06619561·Phase 2·Recruiting·Listed Oct 2024
PROGRESS: Management of Moderate Aortic Stenosis by Clinical Surveillance or TAVR
for Aortic Stenosis, Calcific
Sites in Dallas, Plano +48 more locations
Sponsor: Edwards Lifesciences
Sex: All·Age: 65+
Code: NCT04889872·Recruiting·Listed May 2021
Fontan Udenafil Exercise Longitudinal Assessment Trial - 2
for Single Ventricle Heart Disease
Sites in Dallas, Houston +35 more locations
Sponsor: Mezzion Pharma Co. Ltd
Sex: All·Age: 12 - 18
Code: NCT05918211·Phase 3·Recruiting·Listed Jun 2023
Common conditions studied in Dallas
- Heart Failure (33 active studies)
- Breast Cancer (30 active studies)
- Obesity (26 active studies)
- Prostate Cancer (20 active studies)
- Advanced Solid Tumor (18 active studies)
- Overweight (18 active studies)
Leading research sponsors in Dallas
- University of Texas Southwestern Medical Center
- Eli Lilly and Company
- Baylor Research Institute
- AstraZeneca
- National Cancer Institute (NCI)
Frequently asked questions
How many paid clinical trials are currently recruiting in Dallas?
There are approximately 1,565 recruiting clinical trials in Dallas, Texas listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Dallas pay participants?
Most recruiting trials in Dallas compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Dallas?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Dallas?
The most common conditions under active study in Dallas include Heart Failure (33), Breast Cancer (30), Obesity (26), Prostate Cancer (20), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Dallas?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Dallas on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Dallas?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Dallas?
Recruiting research sites in Dallas include University of Texas Southwestern Medical Center, UT Southwestern Medical Center, UT Southwestern/Simmons Cancer Center-Dallas, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Dallas right now?
The largest active categories in Dallas are Cancer & tumors (426), Cardiovascular (130), Neurology & pain (79). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.
What is the address of UT Southwestern Medical Center?
UT Southwestern Medical Center is located at UT Southwestern Medical Center: Research Department, 6000 Harry Hines Blvd, Dallas, TX 75235. Use the Google Maps link in the intro above to get directions.
How do I contact UT Southwestern Medical Center?
You can reach UT Southwestern Medical Center by phone at (214) 633-0022. For questions about a specific trial, use the study coordinator contact listed on the individual study record — click any trial title above to open it.
Browse more clinical trials
Other cities in Texas
Houston, TX(3,049)San Antonio, TX(984)Austin, TX(680)Fort Worth, TX(331)El Paso, TX(189)Plano, TX(169)Tyler, TX(159)Sugar Land, TX(128)Irving, TX(115)The Woodlands, TX(110)Lubbock, TX(106)Bellaire, TX(102)Amarillo, TX(83)Richardson, TX(83)Galveston, TX(82)McAllen, TX(72)McKinney, TX(70)Temple, TX(69)Corpus Christi, TX(66)DeSoto, TX(65)Webster, TX(64)Mesquite, TX(62)Arlington, TX(61)Tomball, TX(53)Waco, TX(52)Abilene, TX(49)Beaumont, TX(48)Cypress, TX(47)Katy, TX(47)Round Rock, TX(47)Kingwood, TX(43)Frisco, TX(42)Edinburg, TX(41)Conroe, TX(39)Lewisville, TX(39)Baytown, TX(37)League City, TX(37)Denton, TX(35)Southlake, TX(34)Humble, TX(33)Denison, TX(32)Brownsville, TX(31)Harlingen, TX(31)Mansfield, TX(31)Weslaco, TX(31)Wichita Falls, TX(31)Shavano Park, TX(28)Georgetown, TX(27)Longview, TX(24)Richmond, TX(24)Allen, TX(23)Carrollton, TX(23)Sherman, TX(22)College Station, TX(21)Fort Sam Houston, TX(20)Garland, TX(20)Flower Mound, TX(19)Bedford, TX(18)Cedar Park, TX(18)Pasadena, TX(18)